Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice

Journal of Clinical Investigation

Volumn 119, Issue 3, 2009, Pages 531-539

  Qatanani, Mohammed ^a   Szwergold, Nava R ^a   Greaves, David R ^b   Ahima, Rexford S ^a   Lazar, Mitchell A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; FATTY ACID; GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1; LIPID; PROTEIN KINASE C THETA; RESISTIN; RNA; SERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL PATHWAY; CONTROLLED STUDY; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPOLYSIS; MACROPHAGE; MOUSE; MUSCLE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMAL STRUCTURES; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD GLUCOSE; CELL MOVEMENT; CYTOKINES; DIETARY FATS; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; ISOENZYMES; LIPID METABOLISM; LIPIDS; LIPOLYSIS; LIPOPROTEIN LIPASE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SKELETAL; PROTEIN KINASE C; RESISTIN; RESTLESS LEGS SYNDROME; SIGNAL TRANSDUCTION;

EID: 67649869416     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37273     Document Type: Article

References (67)

1. Li, Z., Bowerman, S., and Heber, D. 2005. Health ramifications of the obesity epidemic. Surg. Clin. North Am. 85:681-701.
2. Olshansky, S.J. 2005. Projecting the future of U.S. health and longevity. Health Aff. (Millwood). 24(Suppl. 2):W5R86-W5R89.
3. American Diabetes Association. 2007. Total prevalence of diabetes and pre-diabetes. http://www.diabetes.org/diabetes-statistics/prevalence.jsp.
4. Zimmet, P., Alberti, K.G., and Shaw, J. 2001. Global and societal implications of the diabetes epidemic. Nature. 414:782-787.
5. Kahn, B.B., and Flier, J.S. 2000. Obesity and insulin resistance. J. Clin. Invest. 106:473-481.
6. Flier, J.S. 2004. Obesity wars: molecular progress confronts an expanding epidemic. Cell. 116:337-350.
7. Qatanani, M., and Lazar, M.A. 2007. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21:1443-1455.
8. Lazar, M.A. 2007. Resistin- and obesity-associated metabolic diseases. Horm. Metab. Res. 39:710-716.
9. Holcomb, I.N., et al. 2000. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19:4046-4055.
10. Kim, K.H., Lee, K., Moon, Y.S., and Sul, H.S. 2001. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276:11252-11256.
11. Steppan, C.M., et al. 2001. The hormone resistin links obesity to diabetes. Nature. 409:307-312.
12. Rajala, M.W., et al. 2004. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 53:1671-1679.
13. Rajala, M.W., Obici, S., Scherer, P.E., and Rossetti, L. 2003. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest. 111:225-230.
14. Satoh, H., et al. 2004. Adenovirus-mediated chronic "hyper- resistinemia" leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114:224-231.
15. Rangwala, S.M., et al. 2004. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes. 53:1937-1941.
16. Banerjee, R.R., et al. 2004. Regulation of fasted blood glucose by resistin. Science. 303:1195-1198.
17. Muse, E.D., et al. 2004. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114:232-239.
18. Kim, K.H., Zhao, L., Moon, Y., Kang, C., and Sul, H.S. 2004. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc. Natl. Acad. Sci. U. S. A. 101:6780-6785.
19. Steppan, C.M., Wang, J., Whiteman, E.L., Birnbaum, M.J., and Lazar, M.A. 2005. Activation of SOCS-3 by resistin. Mol. Cell. Biol. 25:1569-1575.
20. Qi, Y., et al. 2006. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes. 55:3083-3090.
21. McTernan, C.L., et al. 2002. Resistin, central obesity, and type 2 diabetes. Lancet. 359:46-47.
22. McTernan, P.G., et al. 2002. Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 87:2407.
23. Vidal-Puig, A., and O'Rahilly, S. 2001. Resistin: a new link between obesity and insulin resistance? Clin. Endocrinol. (Oxf.) 55:437-438.
24. Wang, H., Chu, W.S., Hemphill, C., and Elbein, S.C. 2002. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87:2520-2524.
25. Smith, S.R., Bai, F., Charbonneau, C., Janderova, L., and Argyropoulos, G. 2003. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes. 52:1611-1618.
26. Osawa, H., et al. 2005. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem. Biophys. Res. Commun. 335:596-602.
27. Osawa, H., et al. 2004. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am. J. Hum. Genet. 75:678-686.
28. Janke, J., Engeli, S., Gorzelniak, K., Luft, F.C., and Sharma, A.M. 2002. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes. Res. 10:1-5.
29. Kielstein, J.T., Becker, B., Graf, S., Brabant, G., Haller, H., and Fliser, D. 2003. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am. J. Kidney Dis. 42:62-66.
30. Patel, L., et al. 2003. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 300:472-476.
31. Lehrke, M., et al. 2004. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 1:e45.
32. Pang, S.S., and Le, Y.Y. 2006. Role of resistin in inflammation and inflammation-related diseases. Cell. Mol. Immunol. 3:29-34.
33. Reilly, M.P., et al. 2005. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 111:932-939.
34. Senolt, L., et al. 2007. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann. Rheum. Dis. 66:458-463.
35. Savage, D.B., et al. 2001. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 50:2199-2202.
36. Gough, P.J., Gordon, S., and Greaves, D.R. 2001. The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology. 103:351-361.
37. Axelsson, J., et al. 2006. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 69:596-604.
38. Piestrzeniewicz, K., et al. 2008. Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction. Metabolism. 57:488-493.
39. Fain, J.N. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74:443-477.
40. Zechner, R., et al. 2000. The role of lipoprotein lipase in adipose tissue development and metabolism. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 4):S53-S56.
41. Kim, J.K., et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 98:7522-7527.
42. Petersen, K.F., and Shulman, G.I. 2006. Etiology of insulin resistance. Am. J. Med. 119:S10-S16.
43. Weisberg, S.P., et al. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116:115-124.
44. Weisberg, S.P., et al. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796-1808.
45. Xu, H., et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821-1830.
46. Rahn Landstrom, T., Mei, J., Karlsson, M., Manganiello, V., and Degerman, E. 2000. Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP. Biochem. J. 346:337-343.
47. Kanda, H., et al. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116:1494-1505.
48. Di Gregorio, G.B., et al. 2005. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes. 54:2305-2313.
49. Verma, S., et al. 2003. Resistin promotes endothelial cell activation: further evidence of adipokineendothelial interaction. Circulation. 108:736-740.
50. Rui, L., et al. 2001. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 107:181-189.
51. Gao, Z., et al. 2002. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J. Biol. Chem. 277:48115-48121.
52. Zhang, H.H., Halbleib, M., Ahmad, F., Manganiello, V.C., and Greenberg, A.S. 2002. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes. 51:2929-2935.
53. Anthonsen, M.W., Ronnstrand, L., Wernstedt, C., Degerman, E., and Holm, C. 1998. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J. Biol. Chem. 273:215-221.
54. Farese, R.V., et al. 2007. Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J. Clin. Invest. 117:2289-2301.
55. Zhang, D., et al. 2007. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 104:17075-17080.
56. Schrauwen-Hinderling, V.B., et al. 2005. Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes. Res. 13:2088-2094.
57. Jensen, D.R., et al. 1997. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am. J. Physiol. 273:R683-R689.
58. Kim, S.J., Nian, C., and McIntosh, C.H. 2007. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J. Biol. Chem. 282:34139- 34147.
59. de Luca, C., and Olefsky, J.M. 2008. Inflammation and insulin resistance. FEBS Lett. 582:97-105.
60. Ort, T., et al. 2005. Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice. Endocrinology. 146:2200-2209.
61. Pravenec, M., et al. 2006. Fat-specific transgenic expression of resistin in the spontaneously hypertensive rat impairs fatty acid re-esterification. Int. J. Obes. (Lond.) 30:1157-1159.
62. Pravenec, M., et al. 2003. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J. Biol. Chem. 278:45209-45215.
63. Rae, C., Robertson, S.A., Taylor, J.M., and Graham, A. 2007. Resistin induces lipolysis and re-esterification of triacylglycerol stores, and increases cholesteryl ester deposition, in human macrophages. FEBS Lett. 581:4877-4883.
64. Guerreiro, P.M., Renfro, J.L., Power, D.M., and Canario, A.V. 2007. The parathyroid hormone family of peptides: structure, tissue distribution, regulation, and potential functional roles in calcium and phosphate balance in fish. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292:R679-R696.
65. He, B., et al. 2002. The murine gene encoding parathyroid hormone: genomic organization, nucleotide sequence and transcriptional regulation. J. Mol. Endocrinol. 29:193-203.
66. Jones, S. 2008. Mini-review: endocrine actions of fibroblast growth factor 19. Mol. Pharm. 5:42-48.
67. Neschen, S., et al. 2005. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2:55-65.